'Sputnik': a programmatic approach to improve tuberculosis treatment adherence and outcome among defaulters

被引:33
作者
Gelmanova, I. Y. [2 ]
Taran, D. V. [3 ]
Mishustin, S. P. [4 ]
Golubkov, A. A. [2 ,5 ]
Solovyova, A. V. [3 ]
Keshavjee, S. [1 ,2 ,5 ]
机构
[1] Harvard Univ, Dept Global Hlth & Social Med, Sch Med, Program Infect Dis & Social Change, Boston, MA 02139 USA
[2] Partners Hlth, Boston, MA USA
[3] Partners Hlth Russia, Moscow, Russia
[4] Tomsk Oblast TB Serv, Tomsk, Russia
[5] Brigham & Womens Hosp, Dept Med, Div Global Hlth Equ, Boston, MA 02115 USA
关键词
treatment adherence; patient-centered; MDR-TB; Tomsk; Russia; MULTIDRUG-RESISTANT TUBERCULOSIS; DIRECTLY OBSERVED THERAPY; RISK-FACTORS; MDR-TB; INDIVIDUALIZED TREATMENT; FOLLOW-UP; RUSSIA; TOMSK; POPULATION; MORTALITY;
D O I
10.5588/ijtld.10.0531
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
SETTING: A novel patient-centered tuberculosis (TB) treatment delivery program, 'Sputnik', was introduced for patients at high risk of treatment default in Tomsk City, Russian Federation. OBJECTIVE: To assess the effects of the Sputnik intervention on patient default rates. DESIGN: We analyzed the characteristics of patients referred to the program, treatment adherence of Sputnik program enrollees before and during the intervention, and final outcomes for all patients referred to the Sputnik program. RESULTS: For patients continuing their existing regimens after referral to the program (n = 46), mean adherence to treatment increased by 56% (from 52% of prescribed doses prior to enrolment to 81%). For patients initiating new regimens after referral (n = 5), mean adherence was 83%. Mean adherence for patients with multidrug-resistant TB (MDR-TB; n = 38) was 79% and for all others (n = 13) it was 89%. The cure rate was 71.1% for patients with MDR-TB, 60% for all others and 68% in the program overall. CONCLUSION: The Sputnik intervention was successful in reducing rates of treatment default among patients at high risk for non-adherence.
引用
收藏
页码:1373 / 1379
页数:7
相关论文
共 49 条
  • [31] Programmes and principles in treatment of multidrug-resistant tuberculosis
    Mukherjee, JS
    Rich, ML
    Socci, AR
    Joseph, JK
    Virú, FA
    Shin, SS
    Furin, JJ
    Becerra, MC
    Barry, DJ
    Kim, JY
    Bayona, J
    Farmer, P
    Fawzi, MCS
    Seung, KJ
    [J]. LANCET, 2004, 363 (9407) : 474 - 481
  • [32] Causes of declining life expectancy in Russia
    Notzon, FC
    Komarov, YM
    Ermakov, SP
    Sempos, CT
    Marks, JS
    Sempos, EV
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (10): : 793 - 800
  • [33] Ollé-Goig JE, 2001, INT J TUBERC LUNG D, V5, P137
  • [34] Ollé-Goig JE, 2005, INT J TUBERC LUNG D, V9, P765
  • [35] Palmero DJ, 2004, INT J TUBERC LUNG D, V8, P778
  • [36] Park SK, 2004, INT J TUBERC LUNG D, V8, P361
  • [37] PERELMAN M, 2004, INT J TUBERC LUNG D, V4, P1097
  • [38] Social factors and increase in mortality in Russia in the 1990s: prospective cohort study
    Plavinski, SL
    Plavinskaya, SI
    Klimov, AN
    [J]. BRITISH MEDICAL JOURNAL, 2003, 326 (7401): : 1240 - 1242
  • [39] Portaels F, 1999, INT J TUBERC LUNG D, V3, P582
  • [40] Risk factors for drug resistant tuberculosis in Leicestershire - poor adherence to treatment remains an important cause of resistance
    Pritchard, AJ
    Hayward, AC
    Monk, PN
    Neal, KR
    [J]. EPIDEMIOLOGY AND INFECTION, 2003, 130 (03) : 481 - 483